Skip to main content

Advertisement

Log in

Multidrug — resistant typhoid fever

  • Original Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Objective

To study the epidemiological pattern, clinical picture, the recent trends of multidrug-resistant typhoid fever (MDRTF), and therapeutic response of ofloxacin and ceftriaxone in MDRTF.

Methods

The present prospective randomized controlled parallel study was conducted on 93 blood culture-proven Salmonella typhi children. All MDRTF cases were randomized to treatment with ofloxacin or ceftriaxone.

Results

Of 93 children, 62(66.6%) were MDRTF. 24 cases were below 5 years, 26 between 5–10 years and 12 were above 10 years. Male to female ratio was 1.85: 1. Majority of cases came from lower middle socio-economic classes with poor personal hygiene. Fever was the main presenting symptom. Hepatomegaly and splenomegaly was present in 88% and 46% cases respectively. 19(30.6%) cases developed complications. Mean defervescence time with ceftriaxone and ofloxacin was 4.258 and 4.968 days respectively.

Conclusion

MDRTF is still emerging as serious public and therapeutic challenge. Ceftriaxone is well-tolerated and effective drug but expensive whereas ofloxacin is safe, cost-effective and therapeutic alternative in treatment of MDRTF in children with comparable efficacy to ceftriaxone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wasfy MO, Oyofo BA, David JC et al. Isolations and antibiotic susceptibility of Salmonella, Shigella, and Campylobacter from acute enteric infections in Egypt. J Health Popul Nutr 2000; 18: 33–38.

    PubMed  CAS  Google Scholar 

  2. Ivanoff B, Levine MM, Lambert PH. Vaccination against typhoid fever: present status. Bull World Health Organ 1994; 72: 957–971.

    PubMed  CAS  Google Scholar 

  3. Agarwal K S, Singh S K, Kumar N et al. A study of current trends in enteric fever. J Commun Dis 1998; 30(3): 171–174.

    PubMed  CAS  Google Scholar 

  4. Sood S, Kapil A, Das B, Jain Y, Kabra SK. Re-emergence of chloramphenicol-sensitive Salmonella typhi. Lancet 1999; 353: 1241–1242.

    Article  PubMed  CAS  Google Scholar 

  5. Sinha A, Sazawal S, Kumar R et al. Typhoid fever in children aged less than 5 years. Lancet 1999; 354: 734–737.

    Article  PubMed  CAS  Google Scholar 

  6. Kabra S K, Kabra M, Talati A, Soni N, Patel S, Modi R R. Multidrug-resistant typhoid fever. Trop Doct 2000; 30: 195–197.

    PubMed  CAS  Google Scholar 

  7. Wongsawat J, Pancharoen C, Thisyakorn U. Typhoid fever in children: Experience in King Chulalongkorn Memorial Hospital. J Med Assoc Thai 2002; 85: 1247–1250.

    PubMed  Google Scholar 

  8. Bhutta ZA, Naqvi SH, Razzaq ZA et al. Mutidrug-resistant typhoid in children: Presentation and Clinical features. Rev Infect Dis 1991; 13: 832–836.

    PubMed  CAS  Google Scholar 

  9. Rasaily R, Dutta P, Saha MR, Mitra U et al. Multidrug-resistant typhoid fever in hospitalized children: clinical, bacteriological and epidemiological profiles. Eur J Epidemiol 1994; 10: 41–46.

    Article  PubMed  CAS  Google Scholar 

  10. Koul P B, Murali M V, Sharma P P, Ghai O P, et al. Multidrug-resistant Salmonella typhi infection: clinical profile and therapy. Indian Pediatr 1991; 28: 352–356.

    Google Scholar 

  11. Garg K, Mangal N, Mathur HC. Clinical profile of multidrug-resistant typhoid fever in Jaipur city. Indian Pediatr 1994; 31: 191–193.

    PubMed  CAS  Google Scholar 

  12. Chandra R, Srinivasan S, Nalini P, Rao RS. Multidrug-resistant enteric fever. J Trop Med Hyg 1992; 95: 284–287.

    PubMed  CAS  Google Scholar 

  13. Johnson AOK, Aderele WI. Enteric fever in childhood. J Trop Med Hyg 1981; 84: 29–35.

    PubMed  CAS  Google Scholar 

  14. Vallenas C, Hernandez H, Kay B et al. Efficacy of bone marrow, blood, stool and duodenal contents culture for bacteriologic confirmation of typhoid fever in children. Pediatr Infect Dis 1985; 4: 496–498.

    Article  PubMed  CAS  Google Scholar 

  15. Osler W. Hepatic complication of typhoid fever. Johns Hopkins Hosp Rep 1899; 8: 373–387.

    Google Scholar 

  16. Ramchandaran S, Godfrey JJ, Perera MVF. Typhoid hepatitis. J Am Med Assoc 1974; 230: 236–240.

    Article  Google Scholar 

  17. Biswal N, Mathai B, Bhatia B D, Srinivasan S et al. Enteric fever: A changing perspective. Indian Pediatr 1994; 31: 813–819.

    PubMed  CAS  Google Scholar 

  18. Burnett J W. Uncommon bacterial infections of skin. Arch Dermat 1962; 86: 597–607.

    Google Scholar 

  19. Smith MD, Duong NM, Hoa NT et al. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever. Antimicrob Agents Chemother 1994; 38: 1716–1720.

    PubMed  CAS  Google Scholar 

  20. Asperilla MO, Smego RAJr, Scott LK. Quinolone antibiotics in the treatment of Salmonella infections. Rev Infec Dis 1990; 12: 873–879.

    CAS  Google Scholar 

  21. Ramsey BW. Management of pulmonary disease in patients with cystic fibrosis. N Eng J Med 1996; 335: 179–188.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rajiv Kumar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kumar, R., Gupta, N. & Shalini Multidrug — resistant typhoid fever. Indian J Pediatr 74, 39–42 (2007). https://doi.org/10.1007/s12098-007-0024-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-007-0024-z

Key words

Navigation